Thinking Allowed

Would you pay $1 million to enroll in a phase 1 clinical trial of an

2019-12-03 13:53:53

Would you pay $1 million to enroll in a phase 1 clinical trial of an “anti-aging” gene therapy?

"Libella Gene Therapeutics, LLC made the news last week for announcing a “pay-to-play” trial of its telomerase-based anti-aging gene therapy. What was shocking about the announcement was not that it was a “pay-to-play” trial, given that such trials have become all too common, but rather the price of enrollment: $1 million. Worse, the trial is being conducted in Colombia; the therapy doesn’t have the greatest preclinical justification; and it’s a phase 1 trial, which means it is only trial of safety, not efficacy. How can unethical and scientifically dubious trials like this be stopped?"

Source: sciencebasedmedicine.org

trial gene million phaseclinical anti-aging pay-to-play therapy 1

Related:

• EU Trials Tracker — Who's not sharing clinical trial results? :...
• Clinical trials revolution could change the future of medical...
• Can smartphone drug trials improve medical care?: A new clinical...
• French drug trial turns disastrous, leaving 1 brain dead and...
• Gene therapy staves off blindness from retinitis pigmentosa...